18392

0

MONOPHARMA

img img img img
No Data Available

MONO PHARMACARE LIMITED Share Price Update

As of the latest trading session, MONO PHARMACARE LIMITED is trading at ₹12.5, down by ₹-0.60 or -4.58% from its previous close. The stock has moved between ₹12.50 and ₹12.50 today. Over the past year, the stock has delivered a return of -45.64%. In the last month, it has returned 8.71%.

MONO PHARMACARE LIMITED performance

Today’s low Today’s high
₹ 12.50 ₹ 12.50
₹ 12.50
52 week low 52 week high
₹ 9.45 ₹ 28.25
₹ 12.50
Open Price ₹ 12.50
Prev. Close ₹ 13.10
Volume (Shares) 2000.00
Total traded value ₹ .25
Upper Circuit ₹ 13.75
Lower Circuit ₹ 12.45
info

Investment Returns

Over 1 Month 8.71% Over 3 Months 15.41% Over 6 Months -36.09% Over 1 Year -45.64%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

MONO PHARMACARE LIMITED fundamentals


  • Market cap (Cr) 22.10
  • P/E Ratio (TTM) 7.49
  • Beta 0.47
  • Book Value / share 17.65
  • Return on equity 10.42%
  • EPS (TTM) 1.75
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.00
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

MONO PHARMACARE LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2025 (Values in Cr)
Revenue 82.64
Operating Expense 81.39
Net Profit 3.09
Net Profit Margin (%) 3.73
Earnings Per Share (EPS) 1.75
EBITDA 5.09
Effective Tax Rate (%) 18.03
Particulars MAR 2024 (Values in Cr)
Revenue 70.72
Operating Expense 69.55
Net Profit 2.44
Net Profit Margin (%) 3.45
Earnings Per Share (EPS) 1.59
EBITDA 4.15
Effective Tax Rate (%) 14.33
Particulars MAR 2023 (Values in Cr)
Revenue 45.40
Operating Expense 44.08
Net Profit 1.23
Net Profit Margin (%) 2.70
Earnings Per Share (EPS) 1.80
EBITDA 2.58
Effective Tax Rate (%) 21.01
Particulars MAR 2025 (Values in Cr)
Book Value / Share 17.66
ROE % 10.49
ROCE % 11.01
Total Debt to Total Equity 1.60
EBITDA Margin 5.12
Particulars MAR 2024 (Values in Cr)
Book Value / Share 15.91
ROE % 11.86
ROCE % 10.22
Total Debt to Total Equity 1.97
EBITDA Margin 5.25
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.82
ROE % 5.23
ROCE % 3.16
Total Debt to Total Equity 3.03
EBITDA Margin 6.48
Particulars MAR 2025 (Values in Cr)
Book Value / Share 17.66
ROE % 10.42
ROCE % 10.39
Total Debt to Total Equity 0.62
EBITDA Margin 6.17
Particulars MAR 2024 (Values in Cr)
Book Value / Share 15.91
ROE % 11.76
ROCE % 12.06
Total Debt to Total Equity 0.62
EBITDA Margin 5.87
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.83
ROE % 4.03
ROCE % 4.01
Total Debt to Total Equity 0.93
EBITDA Margin 7.69
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.69
Total Assets 110.05
Total Liabilities 110.05
Total Equity 31.23
Share Outstanding 1
Price to Book Ratio 1.31
Return on Assets (%) 2.80
Return on Capital (%) 3.64
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.36
Total Assets 81.11
Total Liabilities 81.11
Total Equity 28.12
Share Outstanding 1
Price to Book Ratio 2.77
Return on Assets (%) 3.01
Return on Capital (%) 3.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.41
Total Assets 62.60
Total Liabilities 62.60
Total Equity 13.39
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) 1.11
Return on Capital (%) 1.3
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 66.06
Total Liabilities 66.06
Total Equity 31.19
Share Outstanding 1
Price to Book Ratio 1.31
Return on Assets (%) 4.67
Return on Capital (%) 5.63
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 45.40
Total Liabilities 45.40
Total Equity 28.10
Share Outstanding 1
Price to Book Ratio 2.77
Return on Assets (%) 5.37
Return on Capital (%) 5.9
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 29.06
Total Liabilities 29.06
Total Equity 13.39
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) 1.86
Return on Capital (%) 2.09
Particulars MAR 2025 (Values in Cr)
Net Income 4.46
Cash from Operations -2.91
Cash from Investing -0.22
Cash from Financing 4.86
Net change in Cash 0.33
Free Cash Flow -2.68
Particulars MAR 2024 (Values in Cr)
Net Income 3.22
Cash from Operations -8.04
Cash from Investing 0.39
Cash from Financing 8.31
Net change in Cash -0.05
Free Cash Flow -7.86
Particulars MAR 2023 (Values in Cr)
Net Income 0.92
Cash from Operations -27.75
Cash from Investing -1.43
Cash from Financing 29.60
Net change in Cash 0.41
Free Cash Flow -26.89
Particulars MAR 2025 (Values in Cr)
Net Income 3.77
Cash from Operations -0.01
Cash from Investing -7.42
Cash from Financing 8.01
Net change in Cash -0.13
Free Cash Flow 0.16
Particulars MAR 2024 (Values in Cr)
Net Income 2.85
Cash from Operations -9.94
Cash from Investing -1.65
Cash from Financing 11.99
Net change in Cash 0.02
Free Cash Flow -9.91
Particulars MAR 2023 (Values in Cr)
Net Income 0.66
Cash from Operations -13.31
Cash from Investing -2.17
Cash from Financing 15.89
Net change in Cash 0.22
Free Cash Flow -13.10
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.94 13.83 1.65 244.77 23.12 40.44
BLISS GVS PHARMA LTD 271.25 25.93 2.53 2869.53 114.45 280.20
CIPLA LTD. 1304.70 22.17 3.20 105391.40 1165.55 1672.20
FERMENTA BIOTECH LIMITED 282.15 9.39 2.12 830.40 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.94 30.71 4.45 244.77 23.12 40.44
AMRUTANJAN HEALTH CARE LTD. 543.55 24.36 4.24 1571.44 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8538.85 102.62 26.71 21347.13 7630.00 10653.05
BLISS GVS PHARMA LTD 271.25 36.96 2.59 2869.53 114.45 280.20

MONO PHARMACARE LIMITED shareholding pattern

Holding
43.27%
56.72%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

MONO PHARMACARE LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
12.50 -4.58 redarrow
red-green-graph indicator
12 Bearish
4 Bullish
  • 5 Days 12.90
  • 26 Days 12.50
  • 10 Days 12.80
  • 50 Days 13.00
  • 12 Days 12.70
  • 100 Days 15.30
  • 20 Days 12.60
  • 200 Days 20.10
13.07 PIVOT
First Support 13.03 First Resistance 13.13 Second Support 12.97 Second Resistance 13.17 Third Support 12.93 Third Resistance 13.23
RSI 55.56 ADX 24.37 MACD 0.24 Williams % R -29.82 Commodity Channel Index (CCI) 72.76
Date 2026-05-06 Week 23500.00 Same Day 4000.00 Month 14714.00
1 Year 0.48 3 Year 0.70
Over 1 Month
8.71% down
Over 1 Year
-45.64% down
Over 3 Months
15.41% down
Over 3 Years
-24.50% down
Over 6 Months
-36.09% down
Over 5 Years
0.00% down

MONO PHARMACARE LIMITED Corporate Actions

Top Gainers

Top Losers

MONO PHARMACARE LIMITED Share Price

Mono Pharmacare Limited was originally formed as a Partnership Firm in the name and style of 'M/s. Mono Chemist' through Partnership Deed dated May 06, 1994. The Partnership Firm was then converted into Public Limited company in the name of Mono Pharmacare Limited vide Certificate of Incorporation dated October 17, 2022, was issued by the Registrar of Companies, Ahmedabad. The Company is engaged in the business of marketing and distribution of pharmaceutical products.

The product portfolio comprises of a wide range of drugs like Antibiotics, Antifungal, Anti CoughCold & Anti-allergic, Antacid and Antiemetics, Analgesics and Antipyretics, Nutraceuticals, Skincare, Antiseptic, Cardiac and Diabetic & Cosmetics etc. getting products manufactured through contract manufacturing.

Supal Distributors LLP, a Partnership Firm, was incorporated on November 24, 2016, with the Promoters of Company, Panilam Lakhatariya and Supal Lakhatariya, being the Original Partners. Further, Promoters acquired 100% ownership of the partnership firm on July 25, 2019.
Accordingly, Company acquired proprietorship firm of the Promoter, Panilam Lakhatariya M/s DLS Export pursuant to Deed of Business Transfer Agreement dated December 15, 2022 and on October 23, 2020 it acquired 99% ownership of Partnership Firms, M/s. Ahmedabad Medical Corporation (AMC) and M/s. Supal Distributors LLP from the Promoters of Company, Panilam Lakhatariya and Supal Lakhatariya dated January 10, 2023.

In August 2023, Company issued 53,00,000 Equity Shares of Rs 10 each by raising funds through IPO aggregating to Rs 14.84 Crore.

The Company has been acquiring related entities to strengthen its operations. This includes the acquisition of its promoter's proprietorship firm, DLS Export, and 99% ownership of M/s. Ahmedabad Medical Corporation (AMC) and M/s. Supal Distributors LLP in FY 2024.

Parent organization Indian Private
NSE symbol MONOPHARMA
Founded 2022
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Mono Pharmacare Ltd?

Answer Field

Mono Pharmacare Ltd share price is for NSE ₹ 12.50 & for BSE ₹ 0.00 as on May 12 2026 10:09 AM.

What is the Market Cap of Mono Pharmacare Ltd Share?

Answer Field

The market cap of Mono Pharmacare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on May 12 2026 10:09 AM.

What is the 52 Week High and Low of Mono Pharmacare Ltd?

Answer Field

The 52 Week High and Low of Mono Pharmacare Ltd for NSE is ₹ 28.25 and ₹ 9.45 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Mono Pharmacare Ltd?

Answer Field

The 1 year returns on the stock has been -45.64%.

What is the P/E Ratio of Mono Pharmacare Ltd Share?

Answer Field

As on May 12 2026 10:09 AM the price-to-earnings (PE) ratio for Mono Pharmacare Ltd share is 7.49.

What is the PB ratio of Mono Pharmacare Ltd Share?

Answer Field

As on May 12 2026 10:09 AM, the price-to-book (PB) ratio for Mono Pharmacare Ltd share is 17.65.

How to Buy Mono Pharmacare Ltd Share?

Answer Field

You can trade in Mono Pharmacare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Mono Pharmacare Ltd Share on Bajaj Broking App?

Answer Field

To buy Mono Pharmacare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Mono Pharmacare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|